Drug reference

Fluticasone with azelastine

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 1294

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Moderate to severe seasonal and perennial allergic rhinitis, if monotherapy with antihistamine or corticosteroid is inadequate ▶BY INTRANASAL ADMINISTRATION ▶Child 12–17 years: 1 spray twice daily, dose to be administered into each nostril ▶Adult: 1 spray twice daily, dose to be administered into each nostril

PDF page 1294

Safety

Interactions

→Appendix 1: antihistamines, non- sedating. corticosteroids

PDF page 1294

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Spray EXCIPIENTS: May contain Benzalkonium chloride, polysorbates ▶Dymista (Mylan) Fluticasone propionate 50 microgram per 1 actuation, Azelastine hydrochloride 137 microgram per 1 actuation Dymista 137micrograms/dose / 50micrograms/dose nasal spray | 120 dose P £14.80 DT = £14.80 eiiii F 1270

PDF page 1294

Dose text by age group

Child 12–17 years

1 spray twice daily, dose to be

First-line fragment. Read the complete Indications and Dose section above.

PDF page 1294

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Fluticasone with azelastine

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 1294

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

PDF page 1294

Safety

Interactions

→Appendix 1: antihistamines, non- sedating. corticosteroids

PDF page 1294

Dose and formulations

Medicinal Forms

PDF page 1294

Dose text by age group

Child 12–17 years

1 spray twice daily, dose to be

First-line fragment. Read the complete Indications and Dose section above.

PDF page 1294

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.